Progyny, Inc. · NASDAQ:PGNY
Progyny — JP Morgan Healthcare Conference 2026
16 slides from Progyny's conference presentation, January 2026
Slide 1: JP Morgan Presentation
JP Morgan Presentation January 2026 1
Slide 2: Today's Speakers
Today’s Speakers Pete Anevski Melissa Cummings Katie Higgins Mark Livingston Chief Executive Officer Chief Operating Officer Chief Commercial Officer Chief Financial Officer 2
Slide 3: Safe Harbor Statement
Safe Harbor Statement Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements cont
Slide 4: Progyny at a Glance
Progyny at a Glance Our comprehensive coverage, expert care and personalized support make complex journeys simple, while also delivering what matters most: better outcomes, total cost containment and a superior member experience Significant growth since our IPO: 5x more • 33% revenue CAGR1 7x more l
Slide 5: Why buyers prioritize these services and choose Progyny
Why buyers prioritize these services and choose Progyny • Fertility has been a top priority • Buyers remain focused on: among buyers for many years given: • Total cost trend • The underlying incidence and • Addressing multiple drivers to costs prevalence • Member experience • This is a complicated c
Slide 6: Winning on effective program management and total cost control
Winning on effective program management and total cost control Progyny’s Effective Total Cost Management Management of Cost US Medical Cost Trend: 2022 – 20251 ~30% savings • 1.5 fewer driven by our retrievals per 5.4x differential in superior clinical live birth compounded medical cost U.S. +27% ou
Slide 7: Insights from most recent selling season
Insights from most recent selling season • Our proven ability to deliver value shown in: • We remain heavily differentiated by delivering: • Near 100% retention for 10 years running • Value-based care • High rate of expansions, at 30% for 2026 • Total program management, inclusive of cost and outcom
Slide 8: Client base diversification
Client base diversification Largest Industries in 2026 • Over 600 clients in 2026 (in lives) • Our most diverse base ever 1. Healthcare • More than 45 different industries 2. Labor (Taft-Hartley populations) • No industry more than 15% of members 3. Technology • No client expected to be more than a
Slide 9: Market needs addressed by Progyny Select
Market needs addressed by Progyny Select • Infertility is highly prevalent and therefore relevant to all employers • Family-building is highly unique: Targeting Complements employers existing focus • Light/limited plan designs aren’t effective at with 100+ on employers meeting patient needs with 1,0
Slide 10: Why Progyny is best positioned to deliver through Progyny Select
Why Progyny is best positioned to deliver through Progyny Select • Progyny Select is a pooled risk model: • For us, Progyny Select creates a predictable topline contribution and hedge against our • Available to enrollees of the client’s health plan self-insured populations • Leverages our vast datas
Slide 11: Why this is the right time for Progyny Select
Why this is the right time for Progyny Select • We’ve invested the time and resources to build a • Progyny is the first fertility-specific, fully-insured, differentiated solution: premium funded plan: • Meets the unique demands of how this • Providing comprehensive women’s health and market transact
Slide 12: Our newest services
Our newest services • Expands our reach across the employer’s population, while meeting the client’s desire to consolidate with partners who bring proven track records of delivering value • Programs are designed to: Pregnancy Parenting • Augment traditional health plan, while differentiating in Meno
Slide 13: Progyny Global
Progyny Global • Global women’s health and family building • Our Global platform provides: is often disconnected and complex • Simplified benefit administration • With Progyny, employers create equitable and a convenient benefit wallet access for employees everywhere • Care advocates for unlimited,
Slide 14: Cash flow and capital priorities
Cash flow and capital priorities • We’ve engineered our model to produce a high conversion of Cash Flow Conversion Rate Adjusted EBITDA to cash (at least 75% on an annualized basis) Generated over $500M in OCF since the start of 20231 • Recent overage vs. target driven by prudent cash management 110
Slide 15: What are you most excited about for 2026 and beyond?
What are you most excited about for 2026 and beyond? • Continued expansion of core business • Progyny Select, given the significant opportunity, our first-mover advantage and sizeable moat • Leveraging the investments we’ve made – in our platform, products and globally – to advance Progyny as the cl
Slide 16: JP Morgan Presentation
JP Morgan Presentation January 2026 16